For people with persistent seasonal allergies, spring rarely arrives quietly. There is the morning sneeze loop, the itchy eyes by lunch, and the dragging fatigue that settles in by evening. Over-the-counter pills can dull the symptoms, but they rarely fix the underlying overreaction driving them.
That is where allergy immunotherapy for hay fever enters the conversation, especially for people whose symptoms have stopped responding to standard treatments. Allergic rhinitis affects roughly one in four U.S. adults, and the burden is not minor. It interferes with sleep, school performance, productivity, and even mental health.
While antihistamines and nasal corticosteroids remain useful, they only mask symptoms. Hay fever immunotherapy aims to do something different: change how the immune system responds to the allergens in the first place.
This guide walks through how immunotherapy actually works, the differences between allergy shots and sublingual tablets, what current research shows about effectiveness, who tends to benefit most, the side effect profile, treatment timelines, and how to manage hay fever alongside long-term therapy. It closes with the right questions to ask an allergist before starting.
- Allergy immunotherapy for hay fever retrains the immune system to react less to pollen, dust mites, and other airborne allergens over time.
- The two main forms are allergy shots (subcutaneous) and sublingual tablets or drops, both shown to reduce symptoms and medication use.
- Most people need 3 to 5 years of consistent treatment, and improvements often build gradually rather than appearing within weeks.
- Immunotherapy is best for moderate to severe cases or people who do not get enough relief from antihistamines and nasal sprays.
Read More: Sneezing and Sniffling? How to Know If It’s a Cold or Allergies
What Is Allergy Immunotherapy?
Allergy immunotherapy is a long-term treatment that exposes the immune system to small, increasing doses of a specific allergen to teach the body to tolerate it rather than overreact. It is currently the only treatment that modifies the underlying allergic disease rather than just blocking symptoms.
The therapy works through immune system desensitization. Each dose introduces a controlled amount of allergen, and the body gradually shifts from a high-reactivity response to one that produces blocking antibodies and regulatory immune cells. Over months, this rewiring lowers the intensity of allergic responses to environmental allergens like grass pollen.
The goal is not to eliminate the immune system’s awareness of pollen, but to stop it from launching a full inflammatory cascade every time exposure happens. Symptoms tend to soften gradually rather than disappear overnight.
Researchers describe the underlying mechanism as a shift from a TH2-dominant immune response, which drives allergy symptoms, toward a more regulated profile involving allergen-specific IgG4 antibodies and regulatory T cells. This is why immunotherapy is often called disease-modifying, while antihistamines and nasal sprays are considered symptom-modifying.
Two main delivery routes exist. Subcutaneous immunotherapy, known as allergy shots, involves injections given in a clinic on a fixed schedule. Sublingual tablets or drops are placed under the tongue and dissolve, allowing daily home administration after the first dose. Both routes target the same biological pathway through different points of immune contact.
The most commonly treated triggers include grass pollen from timothy, Bermuda, and Kentucky bluegrass; tree pollen such as oak, birch, and cedar; and ragweed. In some cases, dust mites are found in patients with year-round symptoms. Pet dander and certain molds are also addressed when clinically relevant to the patient’s specific exposure pattern.
Most U.S. allergists begin with skin prick testing or specific IgE blood panels to confirm which allergens are clinically driving symptoms. This step matters because immunotherapy only works against confirmed sensitivities. Treating broadly without testing wastes time and may delay real relief.
Dr. Manan Shah, an ENT and allergist with Wyndly Health, explains that immunotherapy is the only way to change your immune system for long-term allergy relief, unlike medications that only manage day-to-day symptoms.
How Effective Is Immunotherapy for Hay Fever?
The question of whether immunotherapy actually works for allergic rhinitis has been studied extensively for decades, and the data consistently support its use in appropriately selected patients.
A systematic review and meta-analysis of 19 randomized controlled trials with nearly 3,000 patients found that sublingual immunotherapy with grass allergens significantly reduced both symptom scores and medication use in seasonal allergic rhinitis. Patients reported fewer flare-ups and lower reliance on antihistamines during peak pollen periods.
A separate meta-analysis comparing subcutaneous and sublingual immunotherapy reviewed 36 trials and found both routes effective, with shots showing a somewhat larger reduction in symptom scores than tablets. Importantly, both routes also reduced the need for rescue medications like nasal sprays and oral antihistamines.
Long-term studies suggest the benefits can persist for years after treatment ends. Patients who completed three to five years of either form of immunotherapy frequently report sustained symptom improvement well beyond the active treatment window, distinguishing this approach from medications that only work while being taken.
Most patients do not feel dramatically better in the first few weeks. Some early symptom relief can show up within three to six months, but the bigger, lasting changes take longer. Treatment usually spans several months before the body’s reactivity shifts in a meaningful way.
Howard Boltansky, MD, an allergist at Johns Hopkins, has noted that about 80% of patients respond well to sublingual immunotherapy, with treatment typically continuing for three to five years for durable results.
Outcomes depend on allergy severity, the specific allergen, consistency with the treatment schedule, and individual immune profile. Patients with single-allergen sensitivities and moderate symptoms tend to respond more predictably than those with multiple severe sensitivities.
Adherence is one of the strongest predictors of success. Missing doses, especially during the build-up phase, can slow progress and sometimes require restarting at a lower concentration. Patients who treat the schedule as non-negotiable typically see the strongest results.
Who Might Benefit Most From Allergy Immunotherapy?
Immunotherapy is not the right first step for every hay fever patient, but it can be valuable for a defined group. Those with persistent symptoms that disrupt daily life or last across multiple pollen seasons are strong candidates. Mild, occasional sneezing usually does not justify multi-year treatment.
Nighttime congestion, ongoing fatigue, and impaired focus during pollen season often signal that medications alone are not enough. When quality of life takes a measurable hit, immunotherapy becomes worth considering.
Some people simply do not get adequate relief from antihistamines, nasal corticosteroids, or saline rinses. For them, immunotherapy may offer a longer-term path to symptom control. People tired of daily pill schedules or seasonal allergy cycles often appreciate that immunotherapy aims for sustained improvement rather than perpetual symptom management.
For families, this can also mean fewer missed school or work days during peak pollen weeks. The upfront time investment is real, but many patients describe it as a front-loaded effort that pays back across the following decade.
Read More: Is It Safe to Take Allergy Medicine Every Day? What Experts Want You to Know
Allergy Shots vs Sublingual Tablets: What’s the Difference?
Both routes work through the same mechanism, but the practical experience differs sharply. Subcutaneous immunotherapy starts with a build-up phase of weekly clinic visits for three to six months, during which doses gradually rise. After reaching maintenance dosing, injections drop to roughly once a month and continue for three to five years.
Patients stay under observation for about 30 minutes after each shot to monitor for systemic reactions. Sublingual immunotherapy for allergies uses a tablet or liquid drop placed under the tongue, held for one to two minutes, then swallowed. The first dose is given in the allergist’s office.
After that, patients self-administer daily at home, usually starting two to four months before the relevant pollen season. Allergy shots can cover multiple allergens in one injection, making them practical for people with several sensitivities.
Sublingual tablets are FDA-approved for a narrower list, primarily grass pollen, ragweed, and dust mites. Shots typically have better insurance coverage in the U.S., while some forms of sublingual therapy may not.
Dr. Purvi Parikh, an allergist and immunologist at Allergy and Asthma Associates of Murray Hill and clinical assistant professor at NYU School of Medicine, calls immunotherapy one of the oldest and most effective treatments for reducing allergies and asthma, emphasizing its role in cutting medication dependence.
Potential Side Effects and Safety Considerations
Both routes have a generally favorable safety profile when properly supervised, but real risks exist. Allergy shots commonly cause itching, swelling, or redness at the injection site. Sublingual tablets often produce mouth or throat irritation, oral itching, or mild ear itching during the first few weeks. These reactions usually fade as the body adapts.
Anaphylaxis is the most serious risk, especially with subcutaneous immunotherapy. A 12-year national surveillance study reported roughly one fatal reaction per 2.5 million injection visits, underscoring why shots require medical supervision and a post-injection observation period.
People with uncontrolled asthma or unstable cardiovascular disease or those taking beta-blockers may face a higher risk. An allergist will review medications and conditions before starting treatment to assess suitability.
How Long Does Allergy Immunotherapy Take?
Patience is part of the protocol. Immunotherapy is not designed for fast relief. The build-up phase, lasting three to six months for shots and a few weeks to months for tablets, gradually raises the allergen dose. The maintenance phase keeps doses steady and continues for years.
Shorter courses may produce some relief, but evidence shows that three to five years of consistent therapy creates the most durable benefit.
A JAMA randomized clinical trial demonstrated that two years of sublingual grass pollen immunotherapy was not enough to show sustained tolerance compared with placebo at three-year follow-up, supporting the longer treatment window.
Dr. James Li, a Mayo Clinic allergist, has stated in a Mayo Clinic Minute on fall allergy relief that he routinely discusses allergy shots as a treatment option after testing patients with persistent symptoms, especially when standard medications fall short.
For many patients, symptom reduction persists for years after stopping, sometimes a decade or more. For others, symptoms gradually return, which may justify discussing a second course with an allergist.
What Immunotherapy Can and Cannot Do
Setting realistic expectations is essential before starting. Most patients experience fewer flare-ups, less severe symptoms during pollen season, better sleep, and reduced reliance on antihistamines and nasal sprays. Many can lower their medication doses or stop seasonal use entirely.
The immune system changes slowly. Even with successful treatment, some symptom management may still be needed during heavy pollen days, and complete symptom elimination is uncommon.
Research continues into whether immunotherapy can prevent the development of asthma in allergic children and whether it reduces new allergen sensitization. Newer formulations using recombinant allergens and adjuvants are being studied to improve speed and safety.
Other Ways to Manage Hay Fever Alongside Immunotherapy
Immunotherapy works best when paired with practical exposure reduction and symptom-targeted care. Keeping windows closed on high pollen days, showering after outdoor time, and using HEPA filters indoors all reduce allergen load. Avoiding outdoor activity during early morning peaks helps too.
Wearing wraparound sunglasses outdoors and changing clothes after coming inside can further limit pollen carried into living spaces. Drying laundry indoors during peak season prevents pollen from settling into bedding and clothing. Pet owners should also bathe and brush pets that go outside, since fur traps pollen and transfers it indoors.
Antihistamines, nasal corticosteroid sprays, and saline rinses remain useful, especially during the early treatment phase or peak pollen days. These do not interfere with immunotherapy and can bridge the months before its effects fully take hold.
Second-generation oral antihistamines like cetirizine, loratadine, and fexofenadine are generally preferred for daytime use because they cause less drowsiness than older options.
Nasal corticosteroid sprays such as fluticasone or mometasone work best when started one to two weeks before pollen season. A simple symptom journal, combined with local pollen forecasts, helps identify patterns and adjust treatment timing. Apps now make this straightforward.
Read More: Can Hay Fever Make You Dizzy? Surprising Symptoms of Seasonal Allergies
Questions to Ask an Allergist Before Starting Treatment
A productive consultation usually covers four key areas.
Which Allergens Are Causing My Symptoms: Skin prick or specific IgE blood testing confirms the triggers. Without that, immunotherapy targeting cannot be accurate.
Am I a Good Candidate for Shots or Tablets: This depends on the number of allergens involved, age, asthma status, and other medical conditions.
How Long Before I May Notice Improvement: Setting expectations early avoids frustration. Most allergists describe a six-month checkpoint.
What Side Effects or Costs Should I Expect: Insurance coverage, time off work for clinic visits, and out-of-pocket costs vary widely across U.S. allergy practices. Asking upfront about pricing, covered allergens, and the expected number of visits keeps planning realistic and helps avoid mid-treatment surprises.
Read More: Top 5 Viral Infections Mistaken for Allergies (And How to Spot the Difference)
Key Takeaway
For people whose hay fever has resisted standard treatment, allergy immunotherapy for hay fever offers something that pills and sprays cannot: a real shift in how the immune system responds to airborne triggers. It demands commitment, patience, and consistent follow-through, but for many patients, it transforms what allergy season actually feels like over the long term.
The decision to start should never be rushed. Talk with a board-certified allergist about your specific allergen profile, the severity of your symptoms, and whether shots or sublingual tablets fit better with your lifestyle and medical history. Reasonable expectations matter, since improvement is steady rather than sudden.
For the right candidate, the time and effort tend to pay off. Fewer flare-ups, less dependence on daily medications, and better sleep through pollen season are realistic outcomes. If antihistamines and nasal sprays are no longer doing the job, immunotherapy is worth a serious conversation with your doctor.
Frequently Asked Questions
1. How long does allergy immunotherapy take to work for hay fever?
Most patients begin noticing some reduction in symptoms within three to six months, with greater improvement after the first full pollen season on treatment. Full benefit typically takes 12 to 24 months, and the standard course lasts three to five years.
2. Are allergy shots or sublingual tablets more effective for pollen allergy?
Both are effective. Allergy shots tend to show somewhat larger reductions in symptom scores and can target multiple allergens at once. Sublingual immunotherapy for allergies is more convenient and has a lower risk of serious reactions, but it is FDA-approved for a smaller list of allergens.
3. What are the most common allergy shot side effects?
The most common reactions are local: redness, swelling, or itching at the injection site. Less common systemic reactions can include hives, wheezing, or anaphylaxis, which is why patients wait under observation after each shot.
4. Can hay fever immunotherapy cure allergies permanently?
Immunotherapy is not a guaranteed cure, but many patients experience lasting symptom relief for years, sometimes a decade or longer, after completing treatment. Some symptoms may gradually return, in which case a second course can be considered.
5. Who should not get allergy immunotherapy?
People with uncontrolled asthma, unstable heart disease, or those taking beta-blockers may face higher risks. Pregnant patients are generally advised not to begin immunotherapy, but can usually continue maintenance dosing if already started.
References
- Bernstein, D. I., Wanner, M., Borish, L., & Liss, G. M. (2004). Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001. Journal of Allergy and Clinical Immunology, 113(6), 1129–1136.
- Cleveland Clinic. (2023). Allergy shots: Effectiveness, side effects & what to expect.
- Cleveland Clinic. (2023). Allergic rhinitis (hay fever): Symptoms & treatment.
- Di Bona, D., Plaia, A., Scafidi, V., Leto-Barone, M. S., & Di Lorenzo, G. (2010). Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis. Journal of Allergy and Clinical Immunology, 126(3), 558–566.
- Dretzke, J., Meadows, A., Novielli, N., Huissoon, A., Fry-Smith, A., & Meads, C. (2013). Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: A systematic review and indirect comparison. Journal of Allergy and Clinical Immunology, 131(5), 1361–1366.
- Mayo Clinic News Network. (2024). Mayo Clinic Minute: How to get hay fever relief from fall allergies.
- NPR Health Shots. (2023). More pollen, more allergies: Personalized exposure therapy treats symptoms.
- Parikh, P. (2024). Dr. Purvi Parikh’s approach to personalized allergy and asthma treatment. Haute Beauty.
- Scadding, G. W., Calderon, M. A., Shamji, M. H., et al. (2017). Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: The GRASS randomized clinical trial. JAMA, 317(6), 615–625.
- Wyndly Health. (n.d.). Difference between sublingual immunotherapy and allergy shots.
In this Article
